You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

~ Buy the TRULANCE (plecanatide) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR TRULANCE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TRULANCE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01429987 ↗	The Plecanatide Chronic Idiopathic Constipation (CIC) Study	Completed	Parexel	Phase 2/Phase 3	2011-10-01	This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC).
NCT01429987 ↗	The Plecanatide Chronic Idiopathic Constipation (CIC) Study	Completed	Bausch Health Americas, Inc.	Phase 2/Phase 3	2011-10-01	This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC).
NCT01429987 ↗	The Plecanatide Chronic Idiopathic Constipation (CIC) Study	Completed	Synergy Pharmaceuticals Inc.	Phase 2/Phase 3	2011-10-01	This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC).
NCT01722318 ↗	The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)	Completed	Bausch Health Americas, Inc.	Phase 2	2012-11-01	This is a randomized, 12-week, double-blind, placebo-controlled, dose-ranging study in patients with IBS-C.
NCT01722318 ↗	The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)	Completed	Synergy Pharmaceuticals Inc.	Phase 2	2012-11-01	This is a randomized, 12-week, double-blind, placebo-controlled, dose-ranging study in patients with IBS-C.
NCT01982240 ↗	12-Week Study of Plecanatide for CIC (The CIC3 Study)	Completed	Bausch Health Americas, Inc.	Phase 3	2013-11-01	The purpose of this study is to confirm that the investigational medication, plecanatide, is safe and effective in treating chronic idiopathic constipation.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TRULANCE

Condition Name

Chart
Table

Condition Name for TRULANCE
Intervention	Trials
Chronic Idiopathic Constipation	3
Irritable Bowel Syndrome With Constipation	2
Irritable Bowel Syndrome Characterized by Constipation	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TRULANCE
Intervention	Trials
Constipation	5
Irritable Bowel Syndrome	3
Syndrome	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TRULANCE

Trials by Country

Map
Table

Trials by Country for TRULANCE
Location	Trials
United States	117
Canada	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TRULANCE
Location	Trials
Louisiana	5
Florida	5
California	5
Virginia	5
Texas	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TRULANCE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TRULANCE
Clinical Trial Phase	Trials
Phase 3	1
Phase 2/Phase 3	1
Phase 2	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TRULANCE
Clinical Trial Phase	Trials
Completed	4
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TRULANCE

Sponsor Name

Chart
Table

Sponsor Name for TRULANCE
Sponsor	Trials
Bausch Health Americas, Inc.	5
Synergy Pharmaceuticals Inc.	5
Parexel	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TRULANCE
Sponsor	Trials
Industry	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.